Rifaximin

Rifaximin - Comprehensive Patient Information for Australia

Basic Product Information

Mechanism of Action

Simple explanation: Rifaximin is an antibiotic that works mainly in the gut. It kills or stops the growth of certain harmful bacteria that can cause infections or disrupt normal gut function, while leaving most beneficial bacteria unaffected. Because it stays in the intestines without being absorbed much into the body, it targets the source of infection directly, with minimal effects elsewhere.

For specialists: Rifaximin is a poorly absorbed, non-systemic antibiotic within the rifamycin class. It binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, leading to inhibition of RNA synthesis and bacterial cell death. The minimal (<1%) systemic absorption confers a favourable safety profile and limits the risk of systemic side effects or drug interactions.

Pharmacokinetics

• Absorption: Rifaximin is minimally absorbed (<1%) from the gastrointestinal tract when taken orally in healthy adults.
• Metabolism: Undergoes negligible hepatic metabolism; drug largely remains unchanged in the gut.
• Elimination: Excreted almost entirely in the stools; less than 0.01% appears in the urine.
• Duration of Action: The effect depends on consistent exposure in the gut lumen; half-life is approximately 5.6 hours, but the gut residency ensures continuous local action during treatment course.

Use in Everyday Life & Best Practices (Australia Context)

• Typical uses: Adults most often use rifaximin for treating traveller’s diarrhoea, irritable bowel syndrome with diarrhoea (IBS-D), and hepatic encephalopathy.
• How to use: Always use as directed by your doctor. Swallow tablets whole with water. Adhere strictly to scheduled times for doses.
• Typical dosage (general): For traveller’s diarrhoea, 200 mg three times daily for 3 days; for IBS-D, 550 mg three times daily for 14 days (see 'Dosing by Indication' table for details).
• Australian context: Available from community pharmacies on a prescription, often as part of a specialist plan for gut conditions.
• Storage: Store below 25°C. Keep out of reach of children. Protect from moisture and heat.

Dosing Schedule: Morning vs Evening

• Advantages of morning dosing: Easier to remember with regular breakfast routine; aligns with dosing intervals for three-times-daily regimens.
• Advantages of even spacing: For regimens requiring dosing every 8 hours, spreading doses throughout the day (morning, afternoon, evening) maintains steady effectiveness.
• Disadvantages: Taking late-night doses (if every 8 hours) may disrupt sleep. Set reminders or use pillboxes to maintain regularity.
• Tips: Pair with meals or set alarms on your mobile to ensure you don’t miss a dose, especially for multi-dose cultures common in Australia.

Taking with Food or on an Empty Stomach

• The absorption of rifaximin is minimal and not significantly affected by food.
• You can take rifaximin with or without meals. For many Australians, taking it with food may help prevent mild stomach upset.
• With typical diets in Australia—often featuring a balanced mix of proteins, grains, and vegetables—rifaximin’s tolerability is high regardless of timing in relation to meals.
• Maintain any prescribed dietary restrictions recommended by your healthcare provider (e.g., hepatic diets for liver disease patients).

Interaction Warnings

Rifaximin has few major interactions, but consider the following:

Indications

Dosing According to Clinical Indication

Safety Profile & Side Effects

Rifaximin is generally well tolerated. Side effects are uncommon due to limited absorption, but some may experience:

Guidelines for Proper Use (Advice for Australia Patients)

• Pharmacist advice: Take the full course even if you feel better. Do not share your medication.
• Missed dose: Take as soon as you remember, unless it’s nearly time for the next dose. Do not double up doses.
• Driving and machinery: Rifaximin is unlikely to cause drowsiness, but avoid driving if you feel unwell.
• GP/Clinic follow-up: Arrange follow-up, especially if prescribed for more than 14 days or if long-term use is recommended for hepatic encephalopathy.
• Hygiene: Maintain good hand hygiene, especially with traveller’s diarrhoea, to prevent spreading infection.
• Environment: Store in original packaging away from moisture (especially important in humid or hot parts of Australia).

Alternative Treatment Options

The best alternative depends on your condition, medical history, and other medicines you may be taking. Discuss with your GP or pharmacist for the latest PBS reimbursement advice.

Legal, Registration, and Reimbursement Status in Australia

• Legal status: Rifaximin is a Schedule 4 (S4) medication—prescription only.
• Regulatory approval: Registered with the TGA (Therapeutic Goods Administration).
• PBS listing: PBS-reimbursed for hepatic encephalopathy and IBS-D under certain criteria; check current PBS schedule for updated conditions.
• Special authorisation: May be eligible via Section 100 for specialist or hospital supply in some conditions.

Latest Research & Clinical Guidance (2022–2025)

• Recent systematic reviews (BMC Gastroenterology, 2022–2024) confirm the efficacy and safety of rifaximin for IBS-D in English and international populations.
• Guidelines: The Gastroenterological Society of Australia (GESA) recognises rifaximin as first-line for recurrent hepatic encephalopathy and a major option for IBS-D refractory to other treatments.
• 2023 Cochrane review supports rifaximin in reducing recurrence of hepatic encephalopathy, with a low risk of serious adverse events.
• Emerging data for use in SIBO and inflammatory bowel diseases remain off-label; Australian specialist societies recommend reserved use pending further clinical trial publication.

Availability & Delivery

Pharmacy delivery times to major Australia cities (indicative):

• Sydney, Melbourne, Brisbane: Same/next business day if ordered before 2pm.
• Perth, Adelaide, Canberra, Hobart: 1–2 business days (allow extra for regional/rural areas).
• Remote/Outback: 3–5 business days; check with your pharmacy for express options.

Frequently Asked Questions (FAQ)

1. Can rifaximin affect my regular gut bacteria or cause resistance?
   Because it works primarily in the gut and is not absorbed, rifaximin has a low risk of causing widespread bacterial resistance. A short course is unlikely to disrupt most normal gut flora, but your doctor will weigh up risks with prolonged use.
2. Is rifaximin safe to use with my other medicines?
   Rifaximin rarely interacts with other common medications, but always tell your pharmacist and doctor about all medicines, vitamins, or herbal supplements you are taking. Check the interactions table above for specific concerns.
3. What do I do if I miss a dose?
   Take the missed dose as soon as you remember unless it’s almost time for your next scheduled dose. Never double up doses to “catch up.” If you’re unsure, ask your pharmacist for advice.
4. Can I drink alcohol while using rifaximin?
   While moderate alcohol intake is not known to interact with rifaximin, it’s advisable to avoid alcohol during treatment to speed recovery from gut infections and prevent unnecessary gut irritation.
5. Is it safe in pregnancy or breastfeeding?
   Rifaximin is not usually recommended in pregnancy or while breastfeeding unless clearly needed. Always discuss any potential pregnancy with your GP before starting, stopping, or continuing rifaximin.

Always read the Consumer Medicine Information (CMI) leaflet provided with your medication and consult your healthcare provider for further information unique to your circumstances.